Laura Sutcliffe
Stock Analyst at Citigroup
(0.95)
# 4,163
Out of 5,182 analysts
12
Total ratings
33.33%
Success rate
-9.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $345 → $340 | $209.43 | +62.35% | 5 | Apr 9, 2026 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $22 → $23 | $11.15 | +101.79% | 4 | Feb 24, 2026 | |
| ARGX argenx SE | Initiates: Buy | $390 | $811.09 | -51.92% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $28.46 | - | 2 | Dec 20, 2019 |
ResMed
Apr 9, 2026
Maintains: Buy
Price Target: $345 → $340
Current: $209.43
Upside: +62.35%
Telix Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $22 → $23
Current: $11.15
Upside: +101.79%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $811.09
Upside: -51.92%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $28.46
Upside: -